Pharmacological Activation of Estrogen Receptors-α and -β Differentially Modulates Keratinocyte Differentiation with Functional Impact on Wound Healing
September 2015
in “
International Journal of Molecular Medicine
”
Studysummary This study found that the activation of ER‑β increased keratinocyte proliferation and gene expression related to epidermal regeneration, enhancing wound healing in both cell models and rats.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The study explored how activating estrogen receptors (ERs) affects keratinocyte behavior and wound healing. It was found that stimulating ER-β, but not ER-α, significantly increased keratinocyte proliferation and altered differentiation. HaCaT keratinocytes, expressing both ER types, were treated with ER-α agonist PPT and ER-β agonist DPN. DPN treatment led to more Ki-67-positive cells, a proliferation marker, and higher keratin-19 levels, indicating less differentiation. Conversely, PPT had no significant effect compared to controls. In an in vivo rat model, ER-β activation with DPN sped up epidermal regeneration during wound healing, while ER-α activation did not. These results suggest that ER-β could be a target for therapies aimed at improving wound healing. The study combined human cell culture and rat model data, but the exact number of subjects was not provided.
